Triple

T21057621
Position Surface form Disambiguated ID Type / Status
Subject ocrelizumab E518760 entity
Predicate indication P23161 FINISHED
Object relapsing forms of multiple sclerosis LITERAL FINISHED

How this triple was built (1 step)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: relapsing forms of multiple sclerosis | Statement: [ocrelizumab, indication, relapsing forms of multiple sclerosis]

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b5053ac48190921529544959e906 completed April 16, 2026, 10:08 a.m.
NER Named-entity recognition batch_69e6fd81434c8190aedfddf937f82322 completed April 21, 2026, 4:30 a.m.
Created at: April 16, 2026, 2:37 p.m.